Concurrent hyperfractionated radiotherapy (Hfx RT) and low-dose daily carboplatin/paclitaxel (C/P) in patients with early stage (I/II) non-small cell lung cancer (NSCLC). Long-term results of a phase II study

Results

Naziv:	Concurrent hyperfractionated radiotherapy (Hfx RT) and low-dose daily carboplatin/paclitaxel (C/P) in patients with early stage (I/II) non-small cell lung cancer (NSCLC). Long-term results of a phase II study
Autori:	Jeremic, Branislav; Milicic, Biljana R; Radosavljevic-Asic, Gordana D
Godina:	2005
Publikacija:	LUNG CANCER
ISSN:	0169-5002 Lung Cancer Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 49 str. S282-S282
DOI:	10.1016/S0169-5002(05)81114-6
WoS-ID:	000231307802100
URI:	https://enauka.gov.rs/handle/123456789/801622
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Altmetric

Dimensions

Unpaywall

Google Scholar^TM